A framework for value-creating learning health systems.


Journal

Health research policy and systems
ISSN: 1478-4505
Titre abrégé: Health Res Policy Syst
Pays: England
ID NLM: 101170481

Informations de publication

Date de publication:
09 Aug 2019
Historique:
received: 15 02 2019
accepted: 15 07 2019
entrez: 11 8 2019
pubmed: 11 8 2019
medline: 19 2 2020
Statut: epublish

Résumé

Interest in value-based healthcare, generally defined as providing better care at lower cost, has grown worldwide, and learning health systems (LHSs) have been proposed as a key strategy for improving value in healthcare. LHSs are emerging around the world and aim to leverage advancements in science, technology and practice to improve health system performance at lower cost. However, there remains much uncertainty around the implementation of LHSs and the distinctive features of these systems. This paper presents a conceptual framework that has been developed in Canada to support the implementation of value-creating LHSs. The framework was developed by an interdisciplinary team at the Institut national d'excellence en santé et en services sociaux (INESSS). It was informed by a scoping review of the scientific and grey literature on LHSs, regular team discussions over a 14-month period, and consultations with Canadian and international experts. The framework describes four elements that characterise LHSs, namely (1) core values, (2) pillars and accelerators, (3) processes and (4) outcomes. LHSs embody certain core values, including an emphasis on participatory leadership, inclusiveness, scientific rigour and person-centredness. In addition, values such as equity and solidarity should also guide LHSs and are particularly relevant in countries like Canada. LHS pillars are the infrastructure and resources supporting the LHS, whereas accelerators are those specific structures that enable more rapid learning and improvement. For LHSs to create value, such infrastructures must not only exist within the ecosystem but also be connected and aligned with the LHSs' strategic goals. These pillars support the execution, routinisation and acceleration of learning cycles, which are the fundamental processes of LHSs. The main outcome sought by executing learning cycles is the creation of value, which we define as the striking of a more optimal balance of impacts on patient and provider experience, population health and health system costs. Our framework illustrates how the distinctive structures, processes and outcomes of LHSs tie together with the aim of optimising health system performance and delivering greater value in health systems.

Sections du résumé

BACKGROUND BACKGROUND
Interest in value-based healthcare, generally defined as providing better care at lower cost, has grown worldwide, and learning health systems (LHSs) have been proposed as a key strategy for improving value in healthcare. LHSs are emerging around the world and aim to leverage advancements in science, technology and practice to improve health system performance at lower cost. However, there remains much uncertainty around the implementation of LHSs and the distinctive features of these systems. This paper presents a conceptual framework that has been developed in Canada to support the implementation of value-creating LHSs.
METHODS METHODS
The framework was developed by an interdisciplinary team at the Institut national d'excellence en santé et en services sociaux (INESSS). It was informed by a scoping review of the scientific and grey literature on LHSs, regular team discussions over a 14-month period, and consultations with Canadian and international experts.
RESULTS RESULTS
The framework describes four elements that characterise LHSs, namely (1) core values, (2) pillars and accelerators, (3) processes and (4) outcomes. LHSs embody certain core values, including an emphasis on participatory leadership, inclusiveness, scientific rigour and person-centredness. In addition, values such as equity and solidarity should also guide LHSs and are particularly relevant in countries like Canada. LHS pillars are the infrastructure and resources supporting the LHS, whereas accelerators are those specific structures that enable more rapid learning and improvement. For LHSs to create value, such infrastructures must not only exist within the ecosystem but also be connected and aligned with the LHSs' strategic goals. These pillars support the execution, routinisation and acceleration of learning cycles, which are the fundamental processes of LHSs. The main outcome sought by executing learning cycles is the creation of value, which we define as the striking of a more optimal balance of impacts on patient and provider experience, population health and health system costs.
CONCLUSIONS CONCLUSIONS
Our framework illustrates how the distinctive structures, processes and outcomes of LHSs tie together with the aim of optimising health system performance and delivering greater value in health systems.

Identifiants

pubmed: 31399114
doi: 10.1186/s12961-019-0477-3
pii: 10.1186/s12961-019-0477-3
pmc: PMC6688264
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

79

Références

BMJ. 2007 Jan 20;334(7585):129-32
pubmed: 17235094
N Engl J Med. 2009 Jul 9;361(2):109-12
pubmed: 19494209
Implement Sci. 2009 Aug 07;4:50
pubmed: 19664226
N Engl J Med. 2010 Aug 5;363(6):501-4
pubmed: 20647183
Implement Sci. 2010 Sep 20;5:69
pubmed: 20854677
Sci Transl Med. 2010 Nov 10;2(57):57cm29
pubmed: 21068440
N Engl J Med. 2010 Dec 23;363(26):2477-81
pubmed: 21142528
Can Fam Physician. 2011 Oct;57(10):1165-73
pubmed: 21998237
Ann Intern Med. 2012 Aug 7;157(3):207-10
pubmed: 22868839
Am J Prev Med. 2012 Sep;43(3):337-50
pubmed: 22898128
Virtual Mentor. 2011 Mar 01;13(3):172-5
pubmed: 23127320
Hastings Cent Rep. 2013 Jan-Feb;Spec No:S16-27
pubmed: 23315888
Value Health. 2013 Jan-Feb;16(1 Suppl):S19-23
pubmed: 23317640
Healthc Policy. 2013 May;8(4):87-99
pubmed: 23968640
J Am Med Inform Assoc. 2014 Jul-Aug;21(4):615-20
pubmed: 24821734
J Am Med Inform Assoc. 2014 Jul-Aug;21(4):602-6
pubmed: 24821737
J Am Med Inform Assoc. 2014 Jul-Aug;21(4):596-601
pubmed: 24821738
J Am Med Inform Assoc. 2014 Jul-Aug;21(4):583-6
pubmed: 24821741
J Am Med Inform Assoc. 2014 Jul-Aug;21(4):633-6
pubmed: 24821745
J Clin Oncol. 2014 Aug 1;32(22):2373-9
pubmed: 24912897
Health Aff (Millwood). 2014 Jul;33(7):1163-70
pubmed: 25006142
Health Aff (Millwood). 2014 Jul;33(7):1187-94
pubmed: 25006145
Clin Exp Rheumatol. 2014 Sep-Oct;32(5 Suppl 85):S-147-9
pubmed: 25365105
Ann Fam Med. 2014 Nov-Dec;12(6):573-6
pubmed: 25384822
EGEMS (Wash DC). 2013 Jan 17;1(1):1003
pubmed: 25848555
Implement Sci. 2015 Feb 12;10:21
pubmed: 25889199
Implement Sci. 2015 Apr 21;10:53
pubmed: 25895742
EGEMS (Wash DC). 2015 Mar 10;3(1):1122
pubmed: 25992388
Clin Transl Sci. 2015 Aug;8(4):269-71
pubmed: 26032246
Implement Sci. 2015 Jun 11;10:88
pubmed: 26062907
BMJ Qual Saf. 2015 Aug;24(8):505-15
pubmed: 26065466
J Behav Health Serv Res. 2017 Apr;44(2):177-194
pubmed: 26289563
Healthc Manage Forum. 2015 Nov;28(6):262-4
pubmed: 26347481
EGEMS (Wash DC). 2015 Aug 17;3(1):1168
pubmed: 26357665
Methods Inf Med. 2015;54(6):479-87
pubmed: 26395036
Biomed Res Int. 2015;2015:961526
pubmed: 26539547
Ann Fam Med. 2016 Mar;14(2):159-65
pubmed: 26951592
Healthc Policy. 2016 Feb;11(3):19-31
pubmed: 27027790
Can Fam Physician. 2015 Dec;61(12):1076-84
pubmed: 27035020
Health Inf Manag. 2016 Dec;45(3):121-133
pubmed: 27105481
Curr Hematol Malig Rep. 2016 Aug;11(4):303-10
pubmed: 27262855
Pain. 2016 Sep;157(9):2033-44
pubmed: 27280328
Dev Med Child Neurol. 2017 Feb;59(2):183-191
pubmed: 27545839
J Biomed Inform. 2016 Dec;64:87-92
pubmed: 27693565
J Health Organ Manag. 2016 Oct 10;30(7):1105-1118
pubmed: 27700477
Healthc Pap. 2016;16(1):34-52
pubmed: 27734788
Qual Manag Health Care. 2016 Oct/Dec;25(4):203-212
pubmed: 27749717
J Oncol Pract. 2017 Mar;13(3):151-153
pubmed: 28118109
EGEMS (Wash DC). 2016 Dec 06;4(1):1245
pubmed: 28154834
Am J Gastroenterol. 2017 Mar;112(3):406-408
pubmed: 28195179
Int J Qual Health Care. 2016 Dec 1;28(6):830-837
pubmed: 28423164
Stud Health Technol Inform. 2017;235:96-100
pubmed: 28423763
Yearb Med Inform. 2017 Aug;26(1):16-23
pubmed: 28480469
J Clin Transl Sci. 2017 Feb;1(1):40-44
pubmed: 28515960
Implement Sci. 2017 Jun 23;12(1):78
pubmed: 28645319
Health Serv Res. 2018 Aug;53(4):2615-2632
pubmed: 28777456
BMC Med. 2017 Oct 2;15(1):177
pubmed: 28965492
Implement Sci. 2017 Nov 3;12(1):125
pubmed: 29100551
N C Med J. 2018 Jan-Feb;79(1):62-65
pubmed: 29439109
Lancet. 2018 Apr 28;391(10131):1718-1735
pubmed: 29483027
Curr Oncol. 2018 Feb;25(1):59-66
pubmed: 29507485
Learn Health Syst. 2016 Oct 21;1(1):e10014
pubmed: 31245551
Learn Health Syst. 2016 Oct 21;1(1):e10015
pubmed: 31245552
Learn Health Syst. 2016 Dec 15;1(1):e10018
pubmed: 31245554
Learn Health Syst. 2017 Jun 09;1(3):e10030
pubmed: 31245562
Learn Health Syst. 2017 Oct 17;1(4):e10043
pubmed: 31245572
Learn Health Syst. 2017 Sep 06;2(2):e10037
pubmed: 31245579
Learn Health Syst. 2018 Apr 16;2(2):e10054
pubmed: 31245583

Auteurs

Matthew Menear (M)

Institut national d'excellence en santé et en services sociaux (INESSS), Quebec, Canada. matthew.menear.1@ulaval.ca.
Centre de recherche sur les soins et les services de première ligne de l'Université Laval, Landry-Poulin Pavilion, 2525 chemin de la Canardière, Quebec, QC, G1J 0A4, Canada. matthew.menear.1@ulaval.ca.

Marc-André Blanchette (MA)

Université du Québec à Trois-Rivières, Quebec, Canada.

Olivier Demers-Payette (O)

Institut national d'excellence en santé et en services sociaux (INESSS), Quebec, Canada.

Denis Roy (D)

Institut national d'excellence en santé et en services sociaux (INESSS), Quebec, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH